Below are the most recent publications written about "Renin-Angiotensin System" by people in Profiles.
-
Hornung E, Achanta S, Moss A, Schwaber JS, Vadigepalli R. Multi-organ gene expression analysis and network modeling reveal regulatory control cascades during the development of hypertension in female spontaneously hypertensive rat. PLoS One. 2024; 19(11):e0313252.
-
Fares J, El Fadel O, Zhao J, Li M, Sun J, Roman J, Loizidis G, Summer R. Mortality and Health Outcomes Among Patients With Sarcoidosis Treated With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Chest. 2025 03; 167(3):772-780.
-
Gupta N, Settle L, Brown BR, Armaignac DL, Baram M, Perkins NE, Kaufman M, Melamed RR, Christie AB, Danesh VC, Denson JL, Cheruku SR, Boman K, Bansal V, Kumar VK, Walkey AJ, Domecq JP, Kashyap R, Aston CE. Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19. Crit Care Med. 2022 10 01; 50(10):e744-e758.
-
Zhang YQ, Liu XG, Ding Q, Berguson M, Morris RJ, Liu H, Goldhammer JE. Perioperative Renin-Angiotensin System Inhibitors Improve Major Outcomes of Heart Failure Patients Undergoing Cardiac Surgery: A Propensity-Adjusted Cohort Study. Ann Surg. 2023 04 01; 277(4):e948-e954.
-
Sattar Y, Mukuntharaj P, Zghouzi M, Suleiman AM, Attique H, Ullah W, Sana MK, Zaher N, Mehmood M, Doshi RP, Panchal A, Mir T, Nadeem M, Ali OE, Mohamed M, Bagur R, Elgendy IY, Mamas MA, Alraies MC. Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population. High Blood Press Cardiovasc Prev. 2021 Jul; 28(4):405-416.
-
G?b?l?s L, R?cz I, Hogan M, Remsey-Semmelweis E, Atallah B, AlMahmeed W, AlSindi F, Suri RM, Bhatnagar G, Tuzcu EM. The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection. J Vasc Surg. 2021 06; 73(6):1889-1897.
-
Ding Q, Zhang Z, Liu H, Nie H, Berguson M, Goldhammer JE, Young N, Boyd D, Morris R, Sun J. Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery. Nat Commun. 2019 09 13; 10(1):4202.
-
Inohara T, Manandhar P, Kosinski AS, Matsouaka RA, Kohsaka S, Mentz RJ, Thourani VH, Carroll JD, Kirtane AJ, Bavaria JE, Cohen DJ, Kiefer TL, Gaca JG, Kapadia SR, Peterson ED, Vemulapalli S. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement. JAMA. 2018 12 04; 320(21):2231-2241.
-
Rinc?n J, Correia D, Arcaya JL, Finol E, Fern?ndez A, P?rez M, Yaguas K, Talavera E, Ch?vez M, Summer R, Romero F. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. Life Sci. 2015 Mar 01; 124:81-90.
-
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec 02; 64(21):e1-76.